Yunkang Group Limited (HKG:2325)
Hong Kong · Delayed Price · Currency is HKD 0.5200
+0.0100 (1.96%)
Sep 11, 2026, 3:59 PM HKT
Yunkang Group Market Cap
Yunkang Group has a market cap or net worth of 298.53 million as of September 10, 2026. Its market cap has decreased by -70.69% in one year.
Market Cap
298.53M
Enterprise Value
-791.50M
Revenue
624.49M
Ranking
n/a
PE Ratio
4.26
Stock Price
0.52
ChartMarket Cap Chart
Since May 18, 2022, Yunkang Group's market cap has decreased from 5.21B to 298.53M, a decrease of -94.27%. That is a compound annual growth rate of -48.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 298.53M | -48.48% |
| Dec 31, 2025 | 579.49M | -89.52% |
| Dec 31, 2024 | 5.53B | -25.83% |
| Dec 29, 2023 | 7.46B | -25.55% |
| Dec 30, 2022 | 10.01B | 92.14% |
| May 18, 2022 | 5.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi XDC Cayman | 91.87B |
| Adicon Holdings | 2.90B |
| Guanze Medical Information Industry (Holding) | 2.24B |
| Mega Genomics | 1.58B |
| Kindstar Globalgene Technology | 925.29M |
| China Biotech Services Holdings | 614.71M |
| Biosino Bio-Technology and Science Incorporation | 474.64M |
| China NT Pharma Group Company | 379.60M |